HLA Class I Binding of Mutant EGFR Peptides in NSCLC Is Associated With Improved Survival-Reference-Cited by-同舟云学术

HLA Class I Binding of Mutant EGFR Peptides in NSCLC Is Associated With Improved Survival

Published:2021-01 Issue:1 Volume:16 Page:104-112
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Dimou Anastasios,Grewe Paul,Sidney John,Sette Alessandro,Norman Paul J.,Doebele Robert C.

Funder

LAM Therapeutics

National Institutes of Health

American Association for Cancer Research

Conquer Cancer Foundation

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference35 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. Lung cancer in never smokers--a different disease;Sun;Nat Rev Cancer,2007

3. Genomic landscape of non-small cell lung cancer in smokers and never-smokers;Govindan;Cell,2012

4. Comprehensive molecular profiling of lung adenocarcinoma [published correction appears in Nature. 2014;514:262. Rogers, K [corrected to Rodgers, K]] [published correction appears in Nature. 2018;559:E12];Nature,2014

5. Advances in lung cancer;Pacheco;Oncotarget,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COSMIC-based mutation database enhances identification efficiency of HLA-I immunopeptidome;Journal of Translational Medicine;2024-02-10

2. COSMIC-based mutation database enhances identification efficiency of HLA-I immunopeptidome;2023-09-29

3. Epidermal Growth Factor Receptor-Targeted Neoantigen Peptide Vaccination for the Treatment of Non-Small Cell Lung Cancer and Glioblastoma;Vaccines;2023-09-05

4. HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events;Journal of Cancer Research and Clinical Oncology;2023-01-20

5. Development of multi-epitope vaccine constructs for non-small cell lung cancer (NSCLC) against USA human leukocyte antigen background: an immunoinformatic approach toward future vaccine designing;Expert Opinion on Biological Therapy;2021-09-29